NO166409C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser.

Info

Publication number
NO166409C
NO166409C NO862487A NO862487A NO166409C NO 166409 C NO166409 C NO 166409C NO 862487 A NO862487 A NO 862487A NO 862487 A NO862487 A NO 862487A NO 166409 C NO166409 C NO 166409C
Authority
NO
Norway
Prior art keywords
branched
straight
alkyl
optionally substituted
different
Prior art date
Application number
NO862487A
Other languages
English (en)
Other versions
NO862487D0 (no
NO166409B (no
NO862487L (no
Inventor
Mario Pinza
Ugo Pfeiffer
Carlo Farina
Silvano Banfi
Original Assignee
Isf Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isf Spa filed Critical Isf Spa
Publication of NO862487D0 publication Critical patent/NO862487D0/no
Publication of NO862487L publication Critical patent/NO862487L/no
Publication of NO166409B publication Critical patent/NO166409B/no
Publication of NO166409C publication Critical patent/NO166409C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1024Tetrapeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Luminescent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO862487A 1985-06-21 1986-06-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser. NO166409C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21236/85A IT1222367B (it) 1985-06-21 1985-06-21 Amminoacil derivati di 4(5)-imidazolodinoni adattivita' nootropica:loro preparazione ed uso farmaceutico

Publications (4)

Publication Number Publication Date
NO862487D0 NO862487D0 (no) 1986-06-20
NO862487L NO862487L (no) 1986-12-22
NO166409B NO166409B (no) 1991-04-08
NO166409C true NO166409C (no) 1991-07-24

Family

ID=11178826

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862487A NO166409C (no) 1985-06-21 1986-06-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser.

Country Status (18)

Country Link
US (1) US4703054A (no)
EP (1) EP0207680B1 (no)
JP (1) JPH0688979B2 (no)
KR (1) KR870000305A (no)
AT (1) ATE56020T1 (no)
AU (1) AU590283B2 (no)
CA (1) CA1273450A (no)
DE (1) DE3673709D1 (no)
DK (1) DK290386A (no)
FI (1) FI862422A (no)
GR (1) GR861578B (no)
HU (1) HUT41741A (no)
IL (1) IL79138A (no)
IT (1) IT1222367B (no)
NO (1) NO166409C (no)
NZ (1) NZ216552A (no)
PH (2) PH23229A (no)
ZA (1) ZA864446B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209644B (it) * 1985-06-21 1989-08-30 Isf Spa Composti farmacologicamente attivi.
FR2677984B1 (fr) * 1991-06-21 1994-02-25 Elf Sanofi Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
JP2606026B2 (ja) * 1991-07-09 1997-04-30 コクヨ株式会社 フォルダー
WO2001053269A1 (en) * 2000-01-18 2001-07-26 The Regents Of The University Of California Acid addition salts of imidazolidinones as reaction catalysts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH449029A (de) * 1963-08-12 1967-12-31 Hoffmann La Roche Verfahren zur Herstellung von 4-Imidazolidon-Verbindungen
IT1209644B (it) * 1985-06-21 1989-08-30 Isf Spa Composti farmacologicamente attivi.

Also Published As

Publication number Publication date
EP0207680B1 (en) 1990-08-29
NO862487D0 (no) 1986-06-20
NO166409B (no) 1991-04-08
PH23229A (en) 1989-06-06
EP0207680A2 (en) 1987-01-07
GR861578B (en) 1986-10-21
IT1222367B (it) 1990-09-05
CA1273450A (en) 1990-08-28
NZ216552A (en) 1989-11-28
AU590283B2 (en) 1989-11-02
HUT41741A (en) 1987-05-28
DK290386A (da) 1987-02-11
NO862487L (no) 1986-12-22
IT8521236A0 (it) 1985-06-21
DK290386D0 (da) 1986-06-20
EP0207680A3 (en) 1989-01-18
FI862422A0 (fi) 1986-06-06
US4703054A (en) 1987-10-27
KR870000305A (ko) 1987-02-17
JPS6230763A (ja) 1987-02-09
DE3673709D1 (de) 1990-10-04
JPH0688979B2 (ja) 1994-11-09
PH24336A (en) 1990-06-13
AU5891786A (en) 1986-12-24
FI862422A (fi) 1986-12-22
IL79138A (en) 1991-04-15
ATE56020T1 (de) 1990-09-15
ZA864446B (en) 1987-03-25

Similar Documents

Publication Publication Date Title
IL74631A0 (en) 3-substituted 2-oxindole-1-carboxamides and pharmaceutical compositions containing them
NO166409C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser.
NO168428C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt pyrrolidonderivat
NO168173C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-oxo-1-imidazolidinacetamid-derivater